title: A new method for identifying stem-like cells in esophageal cancer cell lines.
abstract: Cancer stem cells (CSCs) appear to resist chemo-radiotherapy and initiate tumor recurrence in patients. Isolation and further characterization of this subpopulation is important for targeting CSCs. Flow cytometry using Aldefluor, a fluorescent substrate of aldehyde dehydrogenase, has been used to isolate CSCs from various cancer cell lines. However, new techniques are needed to locate and identify CSCs in culture for live-cell analyses such as fluorescence microscopy without introducing artifacts during cell sorting and to observe CSC and non-CSC interactions. Previously, we characterized a distinct CSC subpopulation within human esophageal cancer cell lines (ESCC). In this study we introduce the attached-cell Aldefluor method (ACAM) to detect CSCs in ESCC cell lines (KY-5, KY-10, TE-1, TE-8, YES-1, YES-2). To validate this technique, we isolated CSCs from the YES-2 parental line using standard Aldefluor flow cytometry to create a cell line enriched in CSCs (YES-2CSC). This line showed significantly greater ACAM staining and higher CD44 levels than YES-2. ACAM also showed significantly higher ALDH activity in YES-2CSC than in YES-2S, a cell line that has a diminished CSC subpopulation after having survived treatment with curcumin. ACAM stained cells within tumorspheres made from the CSC-enriched line but not differentiating cells from the tumorspheres. This study also demonstrates a new method for generating and growing tumorspheres without the growth factor supplements normally used in medium to form tumorspheres. ACAM should be evaluated using other cancer cell lines to further substantiate its effectiveness and to characterize CSCs in culture through various imaging techniques.
authors: 1. Department of Biological Sciences, Bowling Green State University, Bowling Green, OH 43403, USA.
authors: Taghreed N
authors: TN
authors: Almanaa
authors: Michael E
authors: ME
authors: Geusz
authors: Roudabeh J
authors: RJ
authors: Jamasbi
keywords: Adherent Cells; Aldefluor; CD44; Cancer Stem Cells; Curcumin.; Esophageal Cancer; Tumorsphere
references: J Cancer Res Clin Oncol. 1993;119(8):441-9
references: 8509434
references: Annu Rev Med. 2007;58:267-84
references: 17002552
references: Cancer Lett. 2010 Jul 1;293(1):65-72
references: 20089354
references: Curr Stem Cell Res Ther. 2008 Dec;3(4):237-46
references: 19075754
references: J Natl Cancer Inst. 2010 Mar 3;102(5):340-51
references: 20164446
references: Stem Cells Dev. 2009 Jan-Feb;18(1):17-25
references: 18573038
references: Cancer Res. 1986 Jul;46(7):3556-9
references: 3708586
references: Prog Mol Biol Transl Sci. 2010;95:113-58
references: 21075331
references: FASEB J. 2007 Dec;21(14):3777-85
references: 17625071
references: PLoS One. 2011;6(6):e21419
references: 21731740
references: Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):781-6
references: 14711994
references: Cancer Res. 2006 Oct 1;66(19):9339-44
references: 16990346
references: Nature. 2001 Nov 1;414(6859):105-11
references: 11689955
references: Cancer. 1992 Jan 15;69(2):277-84
references: 1728357
references: Stem Cells. 2009 May;27(5):1006-20
references: 19415765
references: PLoS One. 2012;7(2):e30590
references: 22363450
references: Pigment Cell Melanoma Res. 2008 Feb;21(1):39-55
references: 18353142
references: Trends Pharmacol Sci. 2009 Jul;30(7):331-2
references: 19523693
references: Mol Cancer Res. 2009 Mar;7(3):330-8
references: 19276181
references: Cancer Lett. 2008 Aug 18;267(1):133-64
references: 18462866
references: Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):327-37
references: 20142235
references: J Neurosci Methods. 2009 Jan 30;176(2):192-9
references: 19215724
references: Cancer Res. 2010 Jan 1;70(1):338-46
references: 20028869
references: Leukemia. 2007 Jul;21(7):1423-30
references: 17476279
references: Stem Cell Res. 2010 Sep;5(2):131-43
references: 20538535
references: Br J Cancer. 2009 Nov 3;101(9):1585-95
references: 19809435
references: Mol Cancer Ther. 2010 Sep;9(9):2450-7
references: 20716638
references: Clin Cancer Res. 2008 Jan 1;14(1):123-9
references: 18172261
references: Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9118-23
references: 10430905
references: Nat Rev Cancer. 2005 Apr;5(4):275-84
references: 15803154
references: Chem Biol Interact. 2012 Jan 5;195(1):52-60
references: 22079344
references: Oncogene. 2006 Jan 12;25(2):278-87
references: 16170359
references: BMC Complement Altern Med. 2012 Oct 24;12:195
references: 23095512
references: Transl Oncol. 2010 Apr;3(2):99-108
references: 20360934
references: BMC Gastroenterol. 2011 Jun 14;11:71
references: 21669008
references: Clin Dev Immunol. 2012;2012:708036
references: 22693526
references: Cancer Lett. 2010 Dec 28;299(2):150-60
references: 20846785
references: Clin Biochem. 1996 Feb;29(1):5-9
references: 8929817
references: Cell Stem Cell. 2009 Jun 5;4(6):568-80
references: 19497285
references: Clin Cancer Res. 2011 Oct 1;17(19):6174-84
references: 21856769
references: Nat Rev Cancer. 2008 Oct;8(10):755-68
references: 18784658
references: Hybrid Hybridomics. 2003 Dec;22(6):367-76
references: 14683596
references: Breast Cancer Res. 2008;10(1):R10
references: 18241344
references: Clin Chem. 2013 Jan;59(1):205-7
references: 23143328
references: Nihon Geka Hokan. 1991 Jan 1;60(1):3-12
references: 1819237
references: Cytometry. 1988 Jan;9(1):1-6
references: 3409781
references: Stem Cells. 2009 Sep;27(9):2220-8
references: 19544409
references: Clin Cancer Res. 2010 Jan 1;16(1):45-55
references: 20028757
references: Transl Oncol. 2009 Dec;2(4):321-8
references: 19956394
references: J Cancer Res Clin Oncol. 2012 Apr;138(4):675-86
references: 22237455
references: Med Oncol. 2012 Jun;29(2):633-9
references: 21484084
references: PLoS One. 2010 Nov 11;5(11):e13943
references: 21085683
references: Lab Invest. 2010 Feb;90(2):234-44
references: 20010854
references: J Biotechnol. 2010 Jul 1;148(1):3-15
references: 20097238
references: Anticancer Res. 2001 Mar-Apr;21(2A):873-8
references: 11396178
references: J Cancer. 2012;3:32-41
references: 22232696
references: BMC Cancer. 2012 Aug 01;12:329
references: 22852552
references: Cancer Res. 2009 Apr 15;69(8):3382-9
references: 19336570